Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m).

Following the acquisition, Trinity Pharma’s management will continue as minority partner, running the business under the supervision of Strides Pharma Asia.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all
“GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia.”

Strides Pharma Asia is a Singaporean pharmaceutical company and a subsidiary of Strides Shasun. The acquisition will enable the company to establish its presence in South Africa.

GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia (GSAL) increasing its total stake to 75%.

The acquisition will enable the UK-based pharmaceutical company to expand its presence in Saudi Arabia.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.